Roslyn Schneider, MD, joined Pfizer in 2006 and is the Global Patient Affairs Lead on Pfizer’s Medical Leadership Team of the Chief Medical Office (CMO). In this newly created role, Dr Schneider drives patient centricity and integration of the voice of the patient throughout the lifecycle of medicines and their development. Just prior to this she worked with the CMO on Medical Strategy and has held other leadership roles in Medical Affairs and Medicine Development at Pfizer.
Dr Schneider received her Bachelor of Science from the Sophie Davis School of Biomedical Education of the City College of New York, MD from Mount Sinai School of Medicine, and later her MSc in Pharmaceutical Medicine from Hibernia College.
Dr Schneider is a retired Clinical Professor of Medicine of Albert Einstein College of Medicine, an Internist, Pulmonologist, Intensivist, and cared for patients at Beth Israel Medical Center, NY, for twenty years. She presented and published primarily in the areas of pulmonary complications of HIV infection, venous thromboembolic disease, medical ethics and medical education. Dr Schneider was a Program Director for the Fellowship in Pulmonary and Critical Care, the Residency in Internal Medicine, and Assistant Chair of the Department of Medicine. She is a fellow of both the American College of Physicians and the American College of Chest Physicians where she Chairs the Clinical Research Network. She also serves as Secretary on the Board of Trustees of the Physician Assistant Foundation, and is on the Advisory Council of the Keck Graduate Institute.